PNI 132
PNI 132, an ionizable lipid derived from the patent WO2020252589A, is useful in the formulation of lipid nanoparticles.
Product Specifications
CAS Number
2568616-81-7
UNSPSC
12352005
Target
Liposome
Type
Oligonucleotides
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pni-132.html
Purity
96.62
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC/C=C\CC1C(CCC1CC(OCC(OCCCCCCCC/C=C\C/C=C\CCCCC)COCCCCCCCC/C=C\C/C=C\CCCCC)=O)OC(C2CCN(CC2)C)=O
Molecular Formula
C58H101NO6
Molecular Weight
908.43
References & Citations
[1]Jain, Nikita; Thomas, Anitha; Brown, Andrew William. Preparation of ionizable lipids for nucleic acid delivery. WO2020252589A
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC427823 20 µg
TCF3 / E2A (TCF3) (NM_001136139) Human Over-expression Lysate
Sign In for Pricing
View Details 
